Pfizer Asks FDA To Greenlight New Omicron Booster Shots, Which Could Arrive This Fall

Deutschland Nachrichten Nachrichten

Pfizer Asks FDA To Greenlight New Omicron Booster Shots, Which Could Arrive This Fall
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 LAist
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

Pfizer and BioNTech have asked the FDA to authorize an updated version of their COVID-19 vaccine for this fall — this one designed specifically to target the omicron subvariants that are dominant in the U.S.

The new"bivalent" booster — meaning it's a mix of two versions of the vaccine — will target both the original coronavirus strain and the BA.4 and BA.5 omicron subvariants.

Following the FDA's guidance, the data the drugmakers are submitting represents a departure from what's been used in earlier vaccine authorizations. "We're going to use all of these data that we've learned through not only this vaccine but decades of viral immunology to say: 'The way to be nimble is that we're going to do those animal studies,", an immunobiologist at the University of Arizona College of Medicine in Tucson, told NPR recently."We're really not going out too far on a limb here."

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

LAist /  🏆 606. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationMyocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationThe risk of myocarditis is substantially higher in the 4 weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, say researchers of new study. CardioTwitter
Weiterlesen »

Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA AuthorizationPfizer-BioNTech Submit the First Omicron COVID-19 Booster for FDA Authorization
Weiterlesen »

Pfizer seeks OK of updated COVID vaccine booster for fallPfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Weiterlesen »

Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 VaccinePfizer, BioNTech Seek FDA Authorization for Updated Covid-19 VaccineThe updated shot, which targets the latest Omicron subvariants as well as the original virus, would be used in a fall booster campaign.
Weiterlesen »

Pfizer seeks OK of updated COVID vaccine booster for fallPfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives
Weiterlesen »

Pfizer seeks OK of updated COVID vaccine booster for fallPfizer seeks OK of updated COVID vaccine booster for fallPfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.
Weiterlesen »



Render Time: 2025-03-07 11:18:38